1,2-dimethylhydrazine multiple interactions ISO RGD:1615754 6480464 [1, 2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of BCR mRNA CTD PMID:22206623 17beta-estradiol affects expression ISO RGD:1317506 6480464 Estradiol affects the expression of BCR mRNA CTD PMID:22574217 17beta-estradiol increases expression ISO RGD:1317506 6480464 Estradiol results in increased expression of BCR mRNA CTD PMID:23019147 2,2',4,4'-Tetrabromodiphenyl ether increases expression EXP 6480464 2 more ... CTD PMID:27291303 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:1317506 6480464 Tetrachlorodibenzodioxin results in increased expression of BCR mRNA CTD PMID:11007951 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of BCR mRNA CTD PMID:34747641 2-butoxyethanol decreases expression ISO RGD:1615754 6480464 n-butoxyethanol results in decreased expression of BCR mRNA CTD PMID:19812364 4,4'-sulfonyldiphenol decreases methylation ISO RGD:1615754 6480464 bis(4-hydroxyphenyl)sulfone results in decreased methylation of BCR exon CTD PMID:33297965 aflatoxin B1 increases methylation ISO RGD:1317506 6480464 Aflatoxin B1 results in increased methylation of BCR gene CTD PMID:28458013 all-trans-retinoic acid decreases expression ISO RGD:1317506 6480464 Tretinoin results in decreased expression of BCR mRNA CTD PMID:33167477 antirheumatic drug decreases expression ISO RGD:1317506 6480464 Antirheumatic Agents results in decreased expression of BCR mRNA CTD PMID:24449571 arsenite(3-) multiple interactions ISO RGD:1317506 6480464 arsenite inhibits the reaction [G3BP1 protein binds to BCR mRNA] CTD PMID:32406909 arsenous acid increases degradation ISO RGD:1317506 6480464 Arsenic Trioxide results in increased degradation of BCR protein mutant form CTD PMID:22898604 arsenous acid increases expression ISO RGD:1317506 6480464 Arsenic Trioxide results in increased expression of BCR mRNA CTD PMID:22521957 arsenous acid decreases expression ISO RGD:1317506 6480464 Arsenic Trioxide results in decreased expression of BCR mRNA, Arsenic Trioxide results in decreased expression of BCR protein mutant form CTD PMID:14633726 more ... arsenous acid multiple interactions ISO RGD:1317506 6480464 Arsenic Trioxide promotes the reaction [CTSB protein results in increased degradation of BCR protein mutant form] more ... CTD PMID:22898604 , PMID:24129092 ATP multiple interactions ISO RGD:1317506 6480464 [BCR protein mutant form co-treated with Adenosine Triphosphate] results in increased phosphorylation of CRKL protein, sorafenib inhibits the reaction [[BCR protein mutant form co-treated with Adenosine Triphosphate] results in increased phosphorylation of CRKL protein] CTD PMID:19366808 atrazine affects methylation EXP 6480464 Atrazine affects the methylation of BCR gene CTD PMID:28931070 benzo[a]pyrene decreases expression ISO RGD:1615754 6480464 Benzo(a)pyrene results in decreased expression of BCR mRNA CTD PMID:19770486 benzo[a]pyrene affects methylation ISO RGD:1317506 6480464 Benzo(a)pyrene affects the methylation of BCR promoter CTD PMID:27901495 benzo[a]pyrene decreases methylation ISO RGD:1615754 6480464 Benzo(a)pyrene results in decreased methylation of BCR intron CTD PMID:27901495 benzo[a]pyrene decreases methylation ISO RGD:1317506 6480464 Benzo(a)pyrene results in decreased methylation of BCR exon CTD PMID:27901495 benzo[a]pyrene decreases expression ISO RGD:1317506 6480464 Benzo(a)pyrene results in decreased expression of BCR mRNA CTD PMID:26238291 benzo[a]pyrene diol epoxide I decreases expression ISO RGD:1317506 6480464 7 more ... CTD PMID:26238291 beta-hexachlorocyclohexane decreases expression ISO RGD:1615754 6480464 beta-hexachlorocyclohexane results in decreased expression of BCR mRNA CTD PMID:25270620 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of BCR mRNA CTD PMID:25181051 , PMID:34947998 bortezomib decreases expression ISO RGD:1317506 6480464 Bortezomib results in decreased expression of BCR mRNA CTD PMID:20977926 caffeine decreases phosphorylation ISO RGD:1317506 6480464 Caffeine results in decreased phosphorylation of BCR protein CTD PMID:35688186 CGP 52608 multiple interactions ISO RGD:1317506 6480464 CGP 52608 promotes the reaction [RORA protein binds to BCR gene] CTD PMID:28238834 chlorpyrifos increases expression ISO RGD:1317506 6480464 Chlorpyrifos results in increased expression of BCR protein CTD PMID:16790487 chlorpyrifos decreases expression EXP 6480464 Chlorpyrifos results in decreased expression of BCR mRNA CTD PMID:18668222 clobetasol decreases expression ISO RGD:1615754 6480464 Clobetasol results in decreased expression of BCR mRNA CTD PMID:27462272 clothianidin decreases expression ISO RGD:1317506 6480464 clothianidin results in decreased expression of BCR mRNA CTD PMID:31626844 cobalt dichloride decreases expression ISO RGD:1317506 6480464 cobaltous chloride results in decreased expression of BCR mRNA CTD PMID:19320972 copper(II) sulfate decreases expression ISO RGD:1317506 6480464 Copper Sulfate results in decreased expression of BCR mRNA CTD PMID:19549813 coumarin decreases phosphorylation ISO RGD:1317506 6480464 coumarin results in decreased phosphorylation of BCR protein CTD PMID:35688186 cyfluthrin increases expression ISO RGD:1317506 6480464 cyfluthrin results in increased expression of BCR protein CTD PMID:16790487 dexamethasone decreases expression EXP 6480464 Dexamethasone results in decreased expression of BCR mRNA CTD PMID:20032058 dexamethasone multiple interactions EXP 6480464 Testosterone inhibits the reaction [Dexamethasone results in decreased expression of BCR mRNA] CTD PMID:20032058 diarsenic trioxide multiple interactions ISO RGD:1317506 6480464 Arsenic Trioxide promotes the reaction [CTSB protein results in increased degradation of BCR protein mutant form] more ... CTD PMID:22898604 , PMID:24129092 diarsenic trioxide decreases expression ISO RGD:1317506 6480464 Arsenic Trioxide results in decreased expression of BCR mRNA, Arsenic Trioxide results in decreased expression of BCR protein mutant form CTD PMID:14633726 more ... diarsenic trioxide increases expression ISO RGD:1317506 6480464 Arsenic Trioxide results in increased expression of BCR mRNA CTD PMID:22521957 diarsenic trioxide increases degradation ISO RGD:1317506 6480464 Arsenic Trioxide results in increased degradation of BCR protein mutant form CTD PMID:22898604 dibutyl phthalate increases expression EXP 6480464 Dibutyl Phthalate results in increased expression of BCR mRNA CTD PMID:21266533 dicrotophos increases expression ISO RGD:1317506 6480464 dicrotophos results in increased expression of BCR mRNA CTD PMID:28302478 ethanol multiple interactions ISO RGD:1615754 6480464 Ethanol affects the expression of and affects the splicing of BCR mRNA CTD PMID:30319688 fenofibrate multiple interactions EXP 6480464 [Fenofibrate co-treated with Diethylnitrosamine] results in increased expression of BCR mRNA CTD PMID:18253720 flavonoids decreases expression ISO RGD:1317506 6480464 Flavonoids results in decreased expression of BCR mRNA CTD PMID:15465739 folic acid decreases expression ISO RGD:1317506 6480464 Folic Acid results in decreased expression of BCR mRNA CTD PMID:21867686 folic acid multiple interactions ISO RGD:1615754 6480464 [1, 2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of BCR mRNA CTD PMID:22206623 gallic acid multiple interactions ISO RGD:1317506 6480464 Gallic Acid promotes the reaction [Imatinib Mesylate results in decreased phosphorylation of [BCR protein mutant form binds to ABL1 protein mutant form]] more ... CTD PMID:22245431 histamine multiple interactions ISO RGD:1317506 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [[BCR protein mutant form binds to ABL1 protein mutant form] which results in increased chemical synthesis of Histamine] more ... CTD PMID:16849647 hydrogen cyanide increases expression ISO RGD:1615754 6480464 Hydrogen Cyanide results in increased expression of BCR mRNA CTD PMID:33914522 irinotecan decreases expression ISO RGD:1317506 6480464 Irinotecan analog results in decreased expression of BCR mRNA CTD PMID:18927307 LY294002 multiple interactions ISO RGD:1317506 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [[BCR protein mutant form binds to ABL1 protein mutant form] which results in increased chemical synthesis of Histamine], 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [[BCR protein mutant form binds to ABL1 protein mutant form] which results in increased expression of HDC mRNA] CTD PMID:16849647 N-nitrosodiethylamine multiple interactions EXP 6480464 [Fenofibrate co-treated with Diethylnitrosamine] results in increased expression of BCR mRNA CTD PMID:18253720 nilotinib multiple interactions ISO RGD:1317506 6480464 nilotinib inhibits the reaction [[BCR protein mutant form binds to ABL1 protein mutant form] which results in increased chemical synthesis of Histamine], nilotinib inhibits the reaction [[BCR protein mutant form binds to ABL1 protein mutant form] which results in increased expression of HDC mRNA] CTD PMID:16849647 nilotinib decreases phosphorylation ISO RGD:1317506 6480464 nilotinib results in decreased phosphorylation of BCR protein mutant form CTD PMID:19878872 Nor-9-carboxy-delta9-THC multiple interactions ISO RGD:1317506 6480464 [Cannabinoids results in increased abundance of 11-nor-delta(9)-tetrahydrocannabinol-9-carboxylic acid] which affects the methylation of BCR gene CTD PMID:30521419 paracetamol increases expression EXP 6480464 Acetaminophen results in increased expression of BCR mRNA CTD PMID:33387578 phenobarbital decreases expression ISO RGD:1615754 6480464 Phenobarbital results in decreased expression of BCR mRNA CTD PMID:25270620 ponatinib decreases phosphorylation ISO RGD:1317506 6480464 ponatinib results in decreased phosphorylation of BCR protein mutant form CTD PMID:19878872 potassium cyanide increases expression ISO RGD:1615754 6480464 Potassium Cyanide results in increased expression of BCR mRNA CTD PMID:33914522 purmorphamine multiple interactions ISO RGD:1317506 6480464 purmorphamine inhibits the reaction [resveratrol results in decreased expression of [BCR protein mutant form binds to ABL1 protein mutant form]] CTD PMID:22397755 quercetin decreases expression ISO RGD:1317506 6480464 Quercetin results in decreased expression of BCR mRNA CTD PMID:14715546 resveratrol multiple interactions ISO RGD:1317506 6480464 purmorphamine inhibits the reaction [resveratrol results in decreased expression of [BCR protein mutant form binds to ABL1 protein mutant form]], resveratrol results in decreased expression of [BCR protein mutant form binds to ABL1 protein mutant form] CTD PMID:22397755 serpentine asbestos increases expression ISO RGD:1317506 6480464 Asbestos, Serpentine results in increased expression of BCR mRNA CTD PMID:21148743 sorafenib multiple interactions ISO RGD:1317506 6480464 sorafenib inhibits the reaction [[BCR protein mutant form co-treated with Adenosine Triphosphate] results in increased phosphorylation of CRKL protein] CTD PMID:19366808 sorafenib decreases phosphorylation ISO RGD:1317506 6480464 sorafenib results in decreased phosphorylation of BCR protein mutant form CTD PMID:19366808 sorafenib decreases activity ISO RGD:1317506 6480464 sorafenib results in decreased activity of BCR protein mutant form CTD PMID:19366808 testosterone multiple interactions EXP 6480464 Testosterone inhibits the reaction [Dexamethasone results in decreased expression of BCR mRNA] CTD PMID:20032058 theophylline increases expression ISO RGD:1317506 6480464 Theophylline results in increased expression of BCR mRNA CTD PMID:16083514 trichostatin A decreases expression ISO RGD:1317506 6480464 trichostatin A results in decreased expression of BCR mRNA CTD PMID:24935251 tungsten decreases expression ISO RGD:1615754 6480464 Tungsten results in decreased expression of BCR mRNA CTD PMID:30912803 valproic acid increases expression ISO RGD:1317506 6480464 Valproic Acid results in increased expression of BCR mRNA CTD PMID:23179753 , PMID:27188386 vinclozolin affects expression EXP 6480464 vinclozolin affects the expression of BCR mRNA CTD PMID:19015723 vinclozolin decreases expression EXP 6480464 vinclozolin results in decreased expression of BCR mRNA CTD PMID:23034163 vorinostat multiple interactions ISO RGD:1317506 6480464 [Dasatinib co-treated with Vorinostat] results in decreased expression of BCR protein mutant form more ... CTD PMID:12446442 more ... vorinostat decreases expression ISO RGD:1317506 6480464 vorinostat results in decreased expression of BCR mRNA mutant form, vorinostat results in decreased expression of BCR protein mutant form CTD PMID:12446442 zinc atom multiple interactions ISO RGD:1317506 6480464 [PCI 5002 co-treated with Zinc] results in increased expression of BCR mRNA CTD PMID:18593933 zinc(0) multiple interactions ISO RGD:1317506 6480464 [PCI 5002 co-treated with Zinc] results in increased expression of BCR mRNA CTD PMID:18593933